Document is current
Any future updates will be listed below
-
Authors
Axenhus, Michael
Bodén, Henrik
Kelly-Pettersson, Paula
Sköldenberg, Olof
-
Funding
Funding for this research was provided by:
Region Stockholm
Amgen
- License Information
-
More Information
Article History
Received: 11 August 2024
Accepted: 31 March 2025
First Online: 8 April 2025
Declarations
:
: The Ethics Committee of the Karolinska Institute and the Swedish Medical Products Agency approved the study. Individual consent was obtained from each patient. The trial is registered at ClinicalTrials.gov (NCT02299817), registered 20th of November 2014.
: Not applicable.
: The authors declare no competing interests.
